iiBIG is proud to be returning to the “Music City” – Nashville, TN on Thursday & Friday – October 13 & 14, 2022 with our 14th Annual ‘Investment and M&A Opportunities in HEALTHCARE.’ The event will be held at the Loews Vanderbilt Hotel.

Where are the best deals? What constitutes a fair valuation multiple in this market? In the aftermath of the pandemic shutdowns, are more distressed opportunities coming to the table? There is no better place to gather this type of intelligence than at an in-person B2B conference like this one, where off-the-record conversations can take place among professionals who are knowledgeable about the true pulse of this market.

iiBIG’s Healthcare M&A series of conferences started in Nashville in 2007 and, have been held there annually (with the exception of 2020 and 2021). This event has become known as one of the ‘must-attend’ executive B2B healthcare events, where a 360 degree cross section of players in the Healthcare M&A ‘food chain’ gather to learn and network. (Click on ‘Past Attendees’ above to get an idea of the types of senior executives and organizations that attend).

This year’s conference will feature an executive faculty of 30+ healthcare investment thought-leaders, who will participate in panel and roundtable sessions on topics like those shown below*:

STATE of the HEALTHCARE INDUSTRY:
The conference opens with this Keynote panel representing transaction services professionals, healthcare leaders, investors and payers on the business and investment opportunities in healthcare in 2022 and beyond. What is the outlook for deal-flow? What has the Covid-19 crisis done to the healthcare middle markets in terms of valuations, staffing and new entrepreneurial start-ups? Will there be a healthy buyers-market in the months ahead or will sellers have the upper hand?

HEALTHCARE OPPORTUNITY ROUNDTABLES:
Following the State of the Industry Panel, attendees will hear from Healthcare Entrepreneurs, Investors and Deal-makers as they take an in-depth look into on some of the following one-hour discussions and Q&A with conference-goers. Among the must-hear sessions:

• Distressed M&A Opportunities in the Healthcare Industry: Picking up the post-Covid 19 Pieces. Is deal-flow picking up in the distressed and turnaround markets?
• Hospital Roundtable: Roll-ups in the Profit and Non-Profit Middle Market Hospital Sectors. Hospitals, more than many other healthcare providers, have been hit hard by full beds, staff shortages and sluggish revenues recently. Will hospitals continue the march toward more consolidations, or will selling previously promising acquisitions mark the coming months?
• Financial Investor’s Middle-Market Healthcare Roundtable: Private Equity, VCs and Other Financial Buyers discuss the market for financial vs. strategic deals.
• Roll-Ups and Multi-Physician Practices: Has burnout, overwork and drop-outs over the last two years caused an acceleration in practice roll-ups?
• Healthcare Real Estate & Senior Housing Roundtable: Middle-Market Senior Housing and other healthcare-related real estate projects have come roaring back to life much more quickly than expected in the aftermath of Covid-19. Is there more growth to be expected in these markets in the 12 to 18 months ahead?
• Transaction Services Roundtable: Valuations, Regulatory Compliance, Due Diligence and more. Transaction consultancies weigh in on the importance of each step in the transaction process before, during and after the deal.
• Healthcare Partnerships and Joint Ventures: When does it make more sense to structure mutually beneficial partnerships than it does to enter into out-and-out mergers?
• Healthcare Lenders Roundtable: Traditional Brick & Mortar Lenders are being increasingly joined in the middle markets by non-bank and other alternative healthcare lenders. Where are the funds coming from to do deals in the months ahead?
• Healthcare Marketing & Branding Roundtable: Considerations Before, During and After a Healthcare Transaction. As healthcare companies come together (or split apart) – what is the new story they need to tell the market? Their employees? Does this moment warrant the development of an entirely new brand – and, if so, how do they capture and hold on to existing brand equities and loyalties?

 *Not all of the topics above will necessarily appear on the final agenda, or other topics may be added based on the interests expressed by our clients. If you wish to propose a topic that is not listed above, please complete our online JOIN OUR FACULTY page where new topics may be proposed.

From the Public and Private Healthcare Companies:

From the Financial & Investment Community:

From the Professional Advisory and Service Provider Community: